Educational Workshops

Delivery of Biologics with Novel Polymeric Constructs chaired by David Brayden, University College Dublin, Ireland, will be offered as a one-day workshop in New York. Attendees will gain knowledge of several multi-disciplinary high, quality drug delivery research programs; access new, unpublished data; and receive up-to-date realistic assessments of the polymer drug delivery field. After attending this educational workshop, attendees will understand how good use of appropriate in vitro and in vivo assessment tools can yield important data, which can be used to drive improvements in polymeric structures. In addition, attendees will be able to apply rationale principles for candidate drug selection for each program presented. The workshop will cover integrated chemistry, pharmacology, pharmaceutical development, preclinical and clinical progress with injected and non-injected delivery of therapeutic and diagnostic conjugates, and examination of novel imaging and assessment technologies for in vitro and in vivo behavior of conjugates. At the conclusion of the workshop, delegates will have gained an understanding of how progress with polymeric systems must involve a range of specific skill sets. This workshop will offer the opportunity for attendees to network with established leaders, scientists and other attendees in polymeric drug delivery.

Generously Co-sponsored by Nitto Denko Corporation

View this Educational Workshop's Invited Speaker & Topic List

Daniel Bar-Shalom of Averrhoa, Denmark; Brigitte Skalsky, Evonik Industries AG, Germany; and Clive Wilson, University of Strathclyde, Scotland, will be chairing the two-day workshop, Oral Drug Delivery: Challenging Patient Groups. The workshop will consider how dosage forms should be tailored to difficult population groups – those unable to swallow such as infants, the young and the elderly, and those who misuse formulations by attempting to destroy the integrity of the dose forms. Attendees will gain an appreciation of the problems and suggested avenues to exploit new market opportunities. Special attention will be given to the problems of taste masking and controlled release NOT based upon monolithical oral dosage forms. Participants will be made familiar with scientific and regulatory issues and be able use the information in appropriate formulation approaches after attending this educational workshop.

Generously Co-sponsored by Egalet A/S and Evonik Industries AG

View this Educational Workshop's Invited Speaker & Topic List

CLOSE LIST

Saturday, July 12, 2008

08:30 – Introduction – Brigitte Skalsky, Evonik Industries AG, Germany

08:35-09:05 - Catherine Tuleu, University of London, U.K., Pediatric Market Needs

09:05-09:45 - Oscar E. Della Pasqua, Leiden University, The Netherlands, Pediatric Pharmacokinetics & Other Pediatric Considerations

09:45-10:15 – BREAK

10:15-10:45 - Mansoor Khan, Food and Drug Administration, U.S.A., Regulatory Considerations: The Pediatric Population

10:45-11:25 - Charles Frey, Coating Place, Inc., U.S.A., Stealth Delivery for the Young: Painting, Perception, and Presentation for the Pediatric Palate

11:25-12:00 - PANEL DISCUSSION

12:00-13:30 – LUNCH provided compliments of the CRS

13:30-14:10 - Daniel Bar-Shalom, Averrhoa, Denmark, Pediatric Formulations for the Future

14:10-14:50 - Clive Wilson, University of Strathclyde, Scotland, Misuse of Formulations - How Robust is Enough?

14:50-15:20 – BREAK

15:20-16:00 - Brigitte Skalsky, Evonik Industries AG, Germany, Alcohol Influence on Drug Release - Concepts for Rugged Formulations

1600-1700 - PANEL DISCUSSION

Sunday, July 13, 2008

08:00 – Introduction – Clive Wilson, University of Strathclyde, Scotland

08:05-08:45 - Patrick J. Crowley, GlaxoSmithKline, U.S.A., Designing Dosage Forms for the Elderly

08:45-09:25 - Judith L. Beizer, St. John’s University, U.S.A., Real Life Experiences: Elderly Patients & Their Difficulties with Oral Dosage Forms

09:25-10:05 - Charles Frey, Coating Place, Inc., U.S.A., Slippery, Small, and Simple: Size, Surface, and Selection Considerations from a Geriatric Perspective

10:05-10:30 – BREAK

10:30-11:10 - John O'Mullane, Schering Plough, U.S.A., OTC Medications for the Elderly

11:10-11:50 - Uwe Koetter, Dr. Koetter Consulting, Switzerland, Herbal Medicine in the EU: Friend or Foe?

11:50-12:20 – Irwin Jacobs, KV Pharmaceuticals, U.S.A., Oral Drug Delivery: Challenging Patient Groups - The Confused Senior

12:20-13:00 - PANEL DISCUSSION

Strategies to Advance the Bioavailability of Low Solubility Drugs is the two-day workshop being chaired by Yvonne Perrie, Aston University, U.K., and Thomas Rades, University of Otago, New Zealand. The educational goals for this workshop are to investigate, understand and develop the underpinning principles that can be used to develop new formulation strategies for the effective application of poorly soluble drugs. By attending this workshop, attendees will gain the knowledge and understanding of both the factors which dictate drug solubility and its subsequent bioavailability. Also, participants will acquire a working knowledge of formulation methods that can be used to improve bioavailability.

Generously Co-sponsored by AstraZeneca, Avanti Polar Lipids, Boehringer-Ingelheim Pharmaceuticals, Inc., and SOLIQS - The global drug delivery business of Abbott

View this Educational Workshop's Invited Speaker & Topic List

CLOSE LIST

Saturday, July 12

08:00 – Introduction – Thomas Rades, University of Otago, New Zealand

08:05-08:50 - Balvinder Vig, Bristol-Myers Squibb, U.S.A., The Theoretical Basis for the Biopharmaceutical Drug Classification (BCS)

08:50-09:35 - Juergen Siepmann, University of Lille, France, The Principles Governing Drug Dissolution

09:35-09:50 – BREAK

09:50-10:35 - Sandra Klein, Johann Wolfgang Goethe University, Germany, Linking Solubility and Dissolution Performance to Bioavailability

10:35-11:25 - Mike Zaworotko, University of South Florida, U.S.A., Increasing Solubility by Crystal Engineering and Co-Crystal Formation

11:25-12:30 – LUNCH provided compliments of the CRS

12:30-13:15 - Karen Krauel-Goellner, Massey University, New Zealand, Increasing Solubility Using Nanocrystals

13:15-14:00 - Thomas Rades, University of Otago, New Zealand, Increasing the Solubility Using Solid Solutions

14:00-14:15 – BREAK

14:15-15:00 - Susanne Page, F. Hoffmann-La Roche Ltd, Switzerland, Factors Driving Formulation Selection

15:00-15:45 - Thorsteinn Loftsson, University of Iceland, Iceland, Pharmaceutical Applications of Cyclodextrins: Basic Science and Formulation Development

15:45-16:30 - Ijeoma Uchegbu, University of London, U.K., Polymeric Bioavailability Enhancers

16:30-17:00 - PANEL DISCUSSION

Sunday, July 13

08:00 – Introduction – Yvonne Perrie, Aston University, U.K.

08:05-08:50 - Marcus Brewster, Johnson & Johnson, Belgium, Pharmaceutical Applications of Cyclodextrins: CMC, Toxicology and Marketed Drug Development

08:50-09:35 - Yvonne Perrie, Aston University, U.K., Increasing the Solubility Using Liposomes

09:35-10:20 - Leab Sek, Merck Sharp & Dohme, U.K., Increasing the Solubility Using Lipid Formulations

10:20-10:35 – BREAK

10:35-11:20 - Jayne Lawrence, King’s College London, U.K., Increasing Solubility Using Micelles and Microemulsions

11:20-12:05 - Chris Porter, Monash University, Australia, 'In Vivo' Transport and Bioavailability: The Effect of Formulation

12:05-12:50 - Wei-Qin (Tony) Tong, Novartis Pharmaceuticals Corporation, U.S.A., Toxicity and Regulatory Considerations of Special Drug Delivery Systems

12:50-13:15 - PANEL DISCUSSION